Home
Conditions
Neoadjuvant Therapy

Clinical trial condition

Neoadjuvant Therapy

Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.

124 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Neoadjuvant Therapy trial results

Active, not recruiting

Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

NCT04947241

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Fifth Affilliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China

View Trial Details

Active, not recruiting

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

NCT07010120

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
Locations: Department of Radiation Oncology Chengdu, Sichuan, China

View Trial Details

Active, not recruiting

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

NCT05882513

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Active, not recruiting

Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial

NCT07492225

Conditions: Neoadjuvant Therapy, Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma Ureter
Locations: Changhai Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT05340270

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +13 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Active, not recruiting

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT05659251

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Active, not recruiting

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

NCT06124378

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Active, not recruiting

Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study

NCT07032220

Conditions: Breast Cancer Surgery, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy (SLNB)
Locations: Study Officials Fuzhou, Fujian, China

View Trial Details

Active, not recruiting

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

NCT04666090

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Active, not recruiting

Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer

NCT06868758

Conditions: HER2 Positive Breast Carcinoma, Neoadjuvant Therapy
Locations: Chongqing General Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Neoadjuvant Therapy

Neoadjuvant Therapy trial results

Related conditions